Last reviewed · How we verify
androgen deprivation therapy — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
androgen deprivation therapy (androgen deprivation therapy) — Jonsson Comprehensive Cancer Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| androgen deprivation therapy TARGET | androgen deprivation therapy | Jonsson Comprehensive Cancer Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- androgen deprivation therapy CI watch — RSS
- androgen deprivation therapy CI watch — Atom
- androgen deprivation therapy CI watch — JSON
- androgen deprivation therapy alone — RSS
Cite this brief
Drug Landscape (2026). androgen deprivation therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/androgen-deprivation-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab